Oppenheimer maintained its Outperform rating on AppLovin (NASDAQ:APP) while highlighting key points for the company from the ...

A popular theory frequently utilized by technical analysts suggests U.S. stocks could be headed for one last leg higher over ...

The End review: all down to the bunker for Joshua Oppenheimer’s bananas, post-apocalyptic musical - 3/5 Tilda Swinton and ...

The director of ‘The End’ discusses getting tips from Werner Herzog and how contemplating catastrophe can make us more human ...

Christopher Nolan’s Oppenheimer was that rare movie that was both a box office hit and a serious award winner. It also had ...

As previously reported, Oppenheimer initiated coverage of Ouster (OUST) with an Outperform rating and $16 price target The firm sees Ouster as ...

Oppenheimer began coverage on shares of Aurora Innovation (NASDAQ:AUR – Free Report) in a report released on Thursday morning ...

Oppenheimer said on Wednesday it no longer expects growth in U.S. investment banking revenue this year and slashed its ...

In a report released today, Matthew Biegler from Oppenheimer reiterated a Buy rating on Zentalis Pharmaceuticals (ZNTL – Research Report), with ...

Written and Directed by Joshua Oppenheimer. Starring Tilda Swinton, George MacKay, Moses Ingram, Michael Shannon, Bronagh ...

Oppenheimer called the expected M&A rebound under the Trump administration “delayed or cancelled” and downgraded to "perform" ...

(JTA) — Friday is not just “Barbie” release day — moviegoers are also planning to fill theaters across the United States to see Christopher Nolan’s “Oppenheimer” biopic. Many hope it ...